Leqvio (inclisiran)
pCPA File Number:
22830
Negotiation Status:
Under consideration for negotiation
Indication(s):
Primary hypercholesterolemia
Sponsor/Manufacturer:
Novartis Pharmaceuticals Canada Inc.
CDA-AMC Project Number:
SR0791-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded:
Not Applicable